线粒体靶向抗氧化肽SS-31对脓毒症急性肾损伤的保护作用
该研究将60只成年雄性C57BL/6小鼠按随机数字表法分为假手术组(10只)、阳性对照组(10只)、脓毒症模型组(20只)和SS-31肽组(20只),以盲肠结扎穿孔术(CLP)复制脓毒症AKI模型。SS-31肽组与阳性对照组于术后30分钟腹腔注射SS-31肽5 mg/kg,假手术组与脓毒症模型组给予等量生理盐水,持续7天。结果显示,与脓毒症模型组相比,SS-31肽组SCr、BUN及AMPK、PGC-1α、cleaved caspase-3蛋白表达均显著降低,肾细胞肿胀减轻、线粒体结构较完整、凋亡细胞数显著减少。作者认为SS-31肽对脓毒症AKI器官功能障碍的保护作用与维持线粒体稳态和抑制细胞凋亡有关。
要点
- 脓毒症模型组较假手术组SCr升高(93.12±11.80 vs. 32.94±3.37 μmol/L)、BUN升高(41.36±6.48 vs. 9.49±3.58 mmol/L),均P<0.05。
- SS-31肽组较脓毒症模型组SCr降低(71.33±10.14 vs. 93.12±11.80 μmol/L)、BUN降低(27.00±5.52 vs. 41.36±6.48 mmol/L),均P<0.05。
- SS-31肽组较脓毒症模型组肾组织凋亡细胞数减少[13.00(9.00, 16.50)vs. 24.00(18.75, 31.00)个,P<0.05]。
- SS-31肽组较脓毒症模型组AMPK/β-actin(0.23±0.01 vs. 0.30±0.02)、PGC-1α/β-actin(0.27±0.02 vs. 0.38±0.03)、cleaved caspase-3/β-actin(0.13±0.01 vs. 0.20±0.01)均降低,均P<0.05。
- 作者认为SS-31肽的保护作用与维持线粒体稳态和抑制细胞凋亡有关;该结果来自小鼠CLP模型,用药为术后30分钟腹腔注射5 mg/kg、持续7天。
适用人群与场景
- 成年雄性C57BL/6小鼠,采用盲肠结扎穿孔术(CLP)复制脓毒症诱导急性肾损伤模型。
- 假手术组仅行开腹术。
处置流程与药物剂量
- SS-31肽组与阳性对照组于术后30分钟腹腔注射SS-31肽5 mg/kg,持续7天。
- 假手术组与脓毒症模型组于术后30分钟腹腔注射等量生理盐水,持续7天。
- 术后24小时经眼眶采血,检测血清肌酐(SCr)和血尿素氮(BUN)。
- 术后7天处死小鼠,取肾组织行HE染色观察病理结构、透射电镜观察线粒体超微结构、TUNEL法检测细胞凋亡、Western blotting检测PGC-1α、AMPK和cleaved caspase-3蛋白表达。
研究设计与关键结果
- 研究类型为动物实验,60只成年雄性C57BL/6小鼠按随机数字表法分为假手术组(10只)、阳性对照组(10只)、脓毒症模型组(20只)和SS-31肽组(20只)。
- 与假手术组比较,脓毒症模型组SCr升高[(93.12±11.80)vs.(32.94±3.37)μmol/L,P<0.05]、BUN升高[(41.36±6.48)vs.(9.49±3.58)mmol/L,P<0.05]。
- 与假手术组比较,脓毒症模型组AMPK/β-actin升高(0.30±0.02 vs. 0.12±0.01,P<0.05)、PGC-1α/β-actin升高(0.38±0.03 vs. 0.16±0.02,P<0.05)、cleaved caspase-3/β-actin升高(0.20±0.01 vs. 0.11±0.02,P<0.05)。
- HE染色显示脓毒症模型组炎症细胞浸润、肾小球基底膜暴露、管腔内可见空泡样透明管型;电镜下线粒体肿胀、嵴消失、膜破裂;凋亡细胞数较假手术组增多[24.00(18.75, 31.00)vs. 2.00(0.72, 3.25)个,P<0.05]。
- 与脓毒症模型组比较,SS-31肽组SCr降低[(71.33±10.14)vs.(93.12±11.80)μmol/L,P<0.05]、BUN降低[(27.00±5.52)vs.(41.36±6.48)mmol/L,P<0.05]。
- 与脓毒症模型组比较,SS-31肽组AMPK/β-actin降低(0.23±0.01 vs. 0.30±0.02,P<0.05)、PGC-1α/β-actin降低(0.27±0.02 vs. 0.38±0.03,P<0.05)、cleaved caspase-3/β-actin降低(0.13±0.01 vs. 0.20±0.01,P<0.05)。
- HE染色显示SS-31肽组细胞肿胀减轻,线粒体结构完整、嵴肿胀减轻、膜结构较完整;凋亡细胞数较脓毒症模型组减少[13.00(9.00, 16.50)vs. 24.00(18.75, 31.00)个,P<0.05]。
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP脓毒症AKI模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为SS-31肽对脓毒症诱导的AKI器官功能障碍具有保护作用,其机制与维持线粒体稳态和抑制细胞凋亡有关。
- 该结果来自小鼠CLP模型,SS-31肽按5 mg/kg于术后30分钟腹腔注射、持续7天给药,尚未在临床患者中验证。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To study the effect and mechanism of mitochondria-targeted antioxidant peptide SS-31 on sepsis-induced acute kidney injury (AKI).
METHODS: Sixty adult male C57BL/6 mice were randomly divided into four groups according to the random number table method: sham group (10 mice), positive control group (10 mice), sepsis model group (20 mice), and SS-31 peptide group (20 mice). The sepsis-induced AKI mouse model was reproduced by cecal ligation and puncture (CLP). The sham group only received laparotomy. SS-31 peptide (5 mg/kg) was intraperitoneally injected in SS-31 peptide group and positive control group 30 minutes after the operation, while an equivalent amount of normal saline was given in sham group and sepsis model group for 7 days. The blood samples were collected 24 hours after the operation from orbit, and the serum was collected to test the serum creatinine (SCr) and blood urea nitrogen (BUN). The mice were sacrificed 7 days after surgery. The kidney tissues were collected to observe the pathologic structure changes under the hematoxylin-eosin (HE) staining by light microscope. And the mitochondrial ultrastructure was checked under the transmission electron microscope. Cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling method (TUNEL). The expression level of peroxisome proliferator-activated receptorγ coactivator-1α (PGC-1α), adenosine monophosphate-activated protein kinase (AMPK), and cleaved caspase-3 protein were tested by Western blotting.
RESULTS: Compared with sham group, the levels of SCr and BUN were significantly increased in sepsis model group [SCr (μmol/L): 93.12±11.80 vs. 32.94±3.37, BUN (mmol/L): 41.36±6.48 vs. 9.49±3.58, both P < 0.05]. The expression levels of AMPK, PGC-1α and cleaved caspase-3 protein increased (AMPK/β-actin: 0.30±0.02 vs. 0.12±0.01, PGC-1α/β-actin: 0.38±0.03 vs. 0.16±0.02, cleaved caspase-3/β-actin: 0.20±0.01 vs. 0.11±0.02, all P < 0.05). HE staining showed that inflammatory cell was infiltrated, glomerular basement membrane was exposed and vacuole-like transparent casts were found in the lumen. Mitochondria were damaged under electron microscope with swelling, ridge disappearance and ruptured membranes, with increasing of apoptotic cells [cells: 24.00 (18.75, 31.00) vs. 2.00 (0.72, 3.25), P < 0.05]. Meanwhile, compared with sepsis model group, the levels of SCr, BUN and the expressions of AMPK, PGC-1α, cleaved caspase-3 protein were significantly decreased in the SS-31 peptide group [SCr (μmol/L): 71.33±10.14 vs. 93.12±11.80, BUN (mmol/L): 27.00±5.52 vs. 41.36±6.48, AMPK/β-actin: 0.23±0.01 vs. 0.30±0.02, PGC-1α/β-actin: 0.27±0.02 vs. 0.38±0.03, cleaved caspase-3/β-actin: 0.13±0.01 vs. 0.20±0.01, all P < 0.05]. HE staining showed that cell swelling reduced, the mitochondrial structure was intact, the ridge swelling was also reduced, and the membrane structure was relatively intact, the number of apoptotic cells was significantly reduced [cells: 13.00 (9.00, 16.50) vs. 24.00 (18.75, 31.00), P < 0.05].
CONCLUSIONS: The protective effect of SS-31 peptide on organ dysfunction induced by sepsis-induced AKI is related to maintaining mitochondrial homeostasis and inhibiting cell apoptosis.
参考来源
- Sun M, Ma J, Ye J, et al. [Protective effect of mitochondria-targeted antioxidant peptide SS-31 in sepsis-induced acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131006. doi:10.3760/cma.j.cn121430-20210719-01063
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。